Insider Transactions Reported by 17 Insiders of Akero Therapeutics, Inc.

Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
Location
South San Francisco, CA

Insiders trading volume in the past year

Akero Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Skorpios Trust Former 10% owner $2.01M Dec 1, 2022
Mark T. Iwicki Director $0 Dec 9, 2025
Yuan Xu Director $0 Dec 9, 2025
Tomas J. Heyman Director $0 Dec 9, 2025
Scott A. Gangloff Chief Technology Officer $0 -$46.5K -100% Dec 9, 2025
Catriona Yale Chief Development Officer $0 -$9.06M -100% Dec 9, 2025
Patrick Lamy Senior VP, Commercial Strategy $0 -$1.42M -100% Dec 9, 2025
Jane Henderson Director $0 -$142K -100% Dec 9, 2025
Chou Judy Director $0 Dec 9, 2025
Timothy Rolph Chief Scientific Officer $0 -$9.16M -100% Dec 9, 2025
Andrew Cheng President and CEO, Director $0 -$15.3M -100% Dec 9, 2025
Seth Loring Harrison Director $0 Dec 9, 2025
Graham G. Walmsley Director $0 +$18.4M Dec 9, 2025
Jonathan Young Chief Operating Officer $0 -$5.1M -100% Dec 9, 2025
William Richard White Chief Financial Officer $0 -$300K -100% Dec 9, 2025
Kevin Bitterman Director Jun 1, 2021
ATP Life Science Ventures, L.P. 10%+ Owner Jun 28, 2021

Recent Insider Transactions by Companies or Individuals for Akero Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.